Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A project aimed at helping people overcome fear of needles will get underway at Oxford University thanks to support from the Beryl Alexander Charity.

Testing out Oxford's GameChange virtual reality therapy, which is designed to treat agoraphobia in patients with psychosis. © University of Oxford
Testing out Oxford's GameChange virtual reality therapy, designed to treat agoraphobia in patients with psychosis

Needle fear is a very common problem: a large-scale study conducted in 2021 found that as many as one in four people may suffer from it, with the issue typically beginning in childhood. This fear can have a significant impact on people’s lives, preventing them from receiving injections or vaccines, or undergoing blood tests.

Although current psychological therapies have proven to be effective, a shortage of therapists means that very few people are able to access professional help. To address this gap, clinical psychologist Professor Daniel Freeman, in the Department of Psychiatry, will lead an interdisciplinary team in developing, testing and trialling a new immersive virtual reality-enabled treatment programme for needle fear. Crucially, the user will be guided through the therapy by a fully automated virtual coach, meaning that the treatment’s delivery can be supported by a range of professionals such as nurses or school pastoral staff, dramatically increasing scalability.

The project will focus on young people between the ages of 11 and 18 years old and will involve those with lived experience of needle fear, as well as medical clinicians, in the design stages. Once built, the treatment is expected to take around three hours to complete and will focus on helping users overcome their fears gradually.

Professor Freeman is a pioneer of virtual reality (VR) psychological therapy, having previously used it to successfully treat several conditions including fear of heights. In a 2018 clinical trial, his ‘I can do heights’ programme was shown to produce better results than the best psychological intervention delivered face-to-face with a therapist, with fear declining by an average of 70 per cent. One participant said: "What I’m noticing is that in day-to-day life I’m much less averse to edges, steps and heights…I feel as if I’m making enormous progress."

VR is an immensely powerful way to address psychological issues, allowing users to try things that they would be reluctant to attempt in real life. VR treatment can also be made compelling and entertaining, while the headsets themselves are increasingly affordable and easy to use. The technology is also particularly popular with young people.

Professor Freeman said:

"We are very excited to conduct this programme of research. It is obviously crucial to take the fear out of one of the most commonly used medical devices. An engaging, effective and automated virtual reality therapy for needle fears could benefit so many people. We will work with young people, computer scientists and psychologists to produce an outstanding VR experience. The new therapy could be used widely in hospitals, vaccination centres and blood donation centres. The funding from the Beryl Alexander Charity is going to set this in motion and we are tremendously grateful for their support."

The project is expected to begin in January 2022 and will run for two years. It has been made possible thanks to a grant from the Beryl Alexander Charity, which was established in 2018 to support research aimed at assisting people suffering from mental health problems.


Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Daniel Freeman moving to Experimental Psychology

He will be leaving the Department of Psychiatry to become Oxford's Chair of Psychology.

Oxford virtual reality spin-out merges with US-based BehaVR

OxfordVR - based on the work of Daniel Freeman - was spun out of the Department of Psychiatry in 2016

Dr Felicity Waite receives British Psychological Society’s May Davidson Award

The May Davidson Award recognises clinical psychologists who have made an outstanding contribution to the development of clinical psychology within the first decade of their work.

Landmark New Clinical Trial Shows Benefits of Automated Virtual Reality (VR) Treatment for Severe Psychological Problems

The gameChange automated VR program is designed to treat agoraphobia in patients with psychosis. In the largest ever clinical trial of virtual reality for mental health, gameChange especially helped people whose anxiety had previously left them virtually housebound.

IF Funds New VR Treatment for Young People with Schizophrenia

The International Foundation has awarded Professor Daniel Freeman and team in the Department of Psychiatry a £1 million grant to develop and test a virtual reality program to help young people with schizophrenia increase their self-confidence.

Virtual reality and real-world health - IF Oxford Science and Ideas Festival 2019

Find out how virtual reality (VR) is used in research to help build confidence and reduce stress in young people. Visit Julia Badger, Lucy Bowes and Aitor Rovira at their IF Festival stand on 28 October between 11 am and 4 pm. Put on a headset, test your reactions and see how your body responds.